Download
slide1 n.
Skip this Video
Loading SlideShow in 5 Seconds..
Supplementary Figure 1 Lewis, et al. PowerPoint Presentation
Download Presentation
Supplementary Figure 1 Lewis, et al.

Supplementary Figure 1 Lewis, et al.

78 Vues Download Presentation
Télécharger la présentation

Supplementary Figure 1 Lewis, et al.

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Cell Death (Ramos) Untreated Proliferation (Ramos) hIgG (crosslinked) Dacetuzumab (soluble) Dacetuzumab (crosslinked) Percent Cell Death (apoptotic + necrotic) Crosslinking Ab Dacetuzumab (soluble) hIgG (crosslinked) Dacetuzumab (crosslinked) CD40 Ligand hIgG (soluble) Untreated mg/ml 1 3 10 1 3 10 10 10 20 1 ng/ml phospho-ERK1/2 MAPK Dacetuzumab (crosslinked) phospho-p38 MAPK IkB-a Dacetuzumab phospho-AKT Untreated 1.00x103 Lane: 1 2 3 4 5 6 7 8 9 10 11 4.12 12.3 37.0 111 333 ng/ml phospho-ERK1/2 MAPK b-Actin Ramos a Dacetuzumab Signaling (RL) b c Supplementary Figure 1 Lewis, et al.